Search results for "RESPIRATORY SYSTEM"

showing 10 items of 1829 documents

Evidence for pleural epithelial-mesenchymal transition in murine compensatory lung growth

2017

In many mammals, including rodents and humans, removal of one lung results in the compensatory growth of the remaining lung; however, the mechanism of compensatory lung growth is unknown. Here, we investigated the changes in morphology and phenotype of pleural cells after pneumonectomy. Between days 1 and 3 after pneumonectomy, cells expressing α-smooth muscle actin (SMA), a cytoplasmic marker of myofibroblasts, were significantly increased in the pleura compared to surgical controls (p < .01). Scanning electron microscopy of the pleural surface 3 days post-pneumonectomy demonstrated regions of the pleura with morphologic features consistent with epithelial-mesenchymal transition (EMT); nam…

MaleB VitaminsThin-Layer Chromatography0301 basic medicinePathologyOrganogenesismedicine.medical_treatmentVimentinBiochemistryMiceSpectrum Analysis Techniques0302 clinical medicineMedicine and Health SciencesElectron MicroscopyRespiratory System ProceduresPneumonectomyLungImage CytometryMicroscopyMultidisciplinarybiologyOrganic CompoundsChromatographic TechniquesQRVitaminsrespiratory systemChemistryPhenotypemedicine.anatomical_structureThoracotomySpectrophotometry030220 oncology & carcinogenesisPhysical SciencesPleuraMedicineScanning Electron MicroscopyMyofibroblastResearch Articlemedicine.medical_specialtyEpithelial-Mesenchymal TransitionImaging TechniquesScienceCompensatory growth (organ)BiotinSurgical and Invasive Medical ProceduresResearch and Analysis Methods03 medical and health sciencesPneumonectomyFluorescence ImagingmedicineAnimalsVimentinEpithelial–mesenchymal transitionLungSurgical ExcisionFluorimetryOrganic ChemistryChemical CompoundsBiology and Life SciencesProteinsrespiratory tract diseasesMice Inbred C57BLCytoskeletal ProteinsPlanar ChromatographyB vitamins030104 developmental biologybiology.proteinMesothelial CellPLOS ONE
researchProduct

Characterisation of a novel airway late phase model in the sensitized guinea pig which uses silica and Bordetella pertussis as adjuvant for sensitiza…

1996

The objective of the present investigation was to validate a novel model of allergic late phase reaction in the airways of conscious guinea pigs by monitoring airway function with CO2-forced respiration. In addition airway inflammation as one possible cause for the development of airway late phase reaction was characterized by a novel technique which consists of bronchoalveolar lavage via the orotracheal route. Guinea pigs were sensitized twice at 2-week intervals with ovalbumin in silica and Bordetella pertussis. Two weeks after the booster sensitization all guinea pigs showed an acute decrease of tidal volume under CO2-forced respiration 5-15 min after antigen challenge. In contrast 42 ou…

MaleBordetella pertussisOvalbuminGuinea PigsAnti-Inflammatory AgentsMethylprednisoloneBordetella pertussisGuinea pigAdjuvants ImmunologicRespiratory HypersensitivityMedicineAnimalsSensitizationPharmacologyCross-Over Studiesmedicine.diagnostic_testbiologybusiness.industryrespiratory systemEosinophilbiology.organism_classificationSilicon Dioxiderespiratory tract diseasesRespiratory Function TestsOvalbuminmedicine.anatomical_structureBronchoalveolar lavageDelayed hypersensitivityImmunologybiology.proteinAirwaybusinessBronchoalveolar Lavage FluidEuropean journal of pharmacology
researchProduct

The Effect of Intranasal Corticosteroids on Asthma Control and Quality of Life in Allergic Rhinitis with Mild Asthma

2011

BACKGROUND: The mechanisms through which rhinitis affects asthma have not been completely elucidated. We explored whether the effect of nasal treatment on asthma control and respiratory-related quality of life (HRQoL) is mediated by inflammatory changes of the upper and lower airways. METHODS: Allergic rhinitics with mild asthma were randomized to a 14-day treatment period with either nasal budesonide 100 mug, 1 puff per nostril twice a day, or placebo. Clinical, functional, and biological evaluations were performed before and after treatment. RESULTS: Twenty subjects (M/F: 10/10; age: 31 +/- 15 years; mean +/- SD) were enrolled, and a total of 17 individuals completely participated in the …

MaleBudesonideNasal cavityrespiratory musclesVital CapacityPediatricsQuality of lifeSurveys and QuestionnairesImmunology and AllergypainBudesonidepostureRhinitisevaluationPerinatology and Child Healthrespiratory systemRespiratory Function Testsasmamedicine.anatomical_structureIntranasalAnesthesiaAdministrationFemaleNasal Cavitymedicine.drugAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyRhinitis Allergic PerennialNostrilMaximal Midexpiratory Flow RateSettore MED/10 - Malattie Dell'Apparato RespiratorioPlaceboasthma; evaluation; musculoskeletal; pain; posture; respiratory muscles; Administration Intranasal; Adult; Asthma; Budesonide; Eosinophils; Female; Glucocorticoids; Humans; Male; Maximal Midexpiratory Flow Rate; Nasal Cavity; Nasal Lavage; Quality of Life; Rhinitis Allergic Perennial; Rhinitis Allergic Seasonal; Surveys and Questionnaires; Vital Capacity; Respiratory Function Tests; Pediatrics Perinatology and Child Health; Immunology and Allergy; Pulmonary and Respiratory MedicineAllergicInternal medicinemedicineHumansGlucocorticoidsAdministration IntranasalAsthmaSeasonalmusculoskeletalbusiness.industryRhinitis Allergic Seasonalasthmamedicine.diseasePerennialrespiratory tract diseasesEosinophilsPediatrics Perinatology and Child HealthNasal LavageQuality of LifeNasal LavageNasal administrationbusinessJournal of Asthma
researchProduct

Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis

2017

Nasal nitric oxide (nNO) is a noninvasive tool that may be helpful in evaluating the inflammatory status in the upper airways [1]. Previous studies report that nNO is elevated in children with Allergic Rhinitis (AR) [2], especially in perennial sensitized subjects [3], and that it may be affected by topical administration of intranasal steroids (INSs) [4]. This article is protected by copyright. All rights reserved.

MaleBudesonideRhinitis Allergic PerennialImmunologyAdministration Intranasal; Budesonide; Child; Double-Blind Method; Eosinophils; Female; Glucocorticoids; Humans; Male; Nasal Obstruction; Nitric Oxide; Rhinitis Allergic Perennial; Sleep; Pediatrics Perinatology and Child Health; Immunology and Allergy; ImmunologyNitric OxidePediatricsNitric oxidelaw.invention03 medical and health scienceschemistry.chemical_compoundAllergic0302 clinical medicineDouble-Blind MethodRandomized controlled triallawHumansImmunology and AllergyMedicineChild030223 otorhinolaryngologyBudesonideGlucocorticoidsChildrenAdministration IntranasalRhinitisbusiness.industryPerinatology and Child HealthNitric oxide metabolismPerennialNasal obstructionNasal nitric oxideEosinophilsIntranasal030228 respiratory systemchemistryAnesthesiaAdministrationPediatrics Perinatology and Child HealthFemaleNasal administrationSleepbusinessmedicine.drug
researchProduct

TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD

2017

Background: The expression and localization of transforming growth factor-β (TGF-β) pathway proteins in different compartments of the lower airways of patients with stable COPD is unclear. We aimed to determine TGF-β pathway protein expression in patients with stable COPD. Methods: The expression and localization of TGF-β pathway components was measured in the bronchial mucosa and peripheral lungs of patients with stable COPD (n = 44), control smokers with normal lung function (n = 24), and control nonsmoking subjects (n = 11) using immunohistochemical analysis. Results: TGF-β1, TGF-β3, and connective tissue growth factor expression were significantly decreased in the bronchiolar epithelium…

MaleCCN2 connective tissue growth factorSmad Proteinsairway inflammationCritical Care and Intensive Care MedicineTRAP-1 transforming growth factor-β receptor-associated binding proteinPulmonary Disease Chronic ObstructiveLAP latency-associated peptideSMAD small mother against decapentaplegicBAMBI CTGF SMAD TGF-B airway inflammation autoimmunityLungTGF transforming growth factorLLC large latent complexBAMBI CTGF SMAD TGF-β Airway Inflammation AutoimmunityautoimmunityMiddle Agedrespiratory systemLTBP latent transforming growth factor-β binding proteinImmunohistochemistryTGIF 5′-TG-3′-interacting factorECM extracellular matrixTGFBI transforming growth factor-β-induced proteinFemaleCardiology and Cardiovascular MedicinePI3K phosphoinositide 3-kinaseSignal TransductionTGF-βPulmonary and Respiratory MedicineTGF-βR TGF-β receptorSocio-culturaleBronchiRespiratory MucosaArticleTGF-BTransforming Growth Factor beta1Transforming Growth Factor beta3Macrophages AlveolarHumansAgedBAMBI; CTGF; SMAD; TGF-β; airway inflammation; autoimmunityBAMBIMembrane ProteinsCTGFBMP bone morphogenetic proteinBAMBI; CTG; SMAD; TGF-β; airway inflammation; autoimmunityCTGBAMBI bone morphogenetic proteins and activin membrane-bound inhibitorrespiratory tract diseasesairway inflammation; autoimmunity; BAMBI; CTGF; SMAD; TGF-β; Pulmonary and Respiratory Medicine; Critical Care and Intensive Care Medicine; Cardiology and Cardiovascular MedicineCase-Control StudiesBiomarkersMAPK mitogen-activated protein kinaseSMAD
researchProduct

Direct true lumen cannulation in type A acute aortic dissection: A review of an 11 years’ experience

2020

ObjectivesDirect true lumen cannulation (DTLC) of the aorta is an alternative cardiopulmonary bypass cannulation technique in the context of type A acute aortic dissection (A-AAD). DTLC has been reported to be effective in restoring adequate perfusion to jeopardized organs. This study reports and compares operative outcomes with DTLC or alternative cannulation techniques in a large cohort of patients with A-AAD.MethodsAll patients who underwent surgery for A-AAD between January 2006 and January 2017 in Mainz university hospital were reviewed. The choice of cannulation technique was left to the operating surgeon, however DTLC was our preference in patients who were in state of shock or showe…

MaleCardiac CatheterizationResuscitationCritical Care and Emergency MedicineCardiovascular ProceduresComputed Tomography AngiographyHealth Care ProvidersCannulationCardiovascular Medicine030204 cardiovascular system & hematologyCardiac CathetersDiagnostic Radiologylaw.inventionPostoperative Complications0302 clinical medicinelawMedicine and Health SciencesMedical PersonnelHospital MortalityProspective StudiesCardiovascular ImagingAortaAortic dissectionCardiopulmonary BypassMultidisciplinaryRadiology and ImagingQRAngiographyMiddle AgedAortic AneurysmSurvival RateProfessionsTreatment OutcomeMedicineFemaleTamponadeAnatomyResearch Articlemedicine.medical_specialtyDeath RatesImaging TechniquesScienceResuscitationCardiologyLumen (anatomy)Surgical and Invasive Medical ProceduresResearch and Analysis Methods03 medical and health sciencesAneurysmPopulation MetricsDiagnostic MedicinePhysiciansmedicineCardiopulmonary bypassCannulaHumansSurvival rateAgedRetrospective StudiesSurgeonsPopulation Biologybusiness.industryBiology and Life SciencesRetrospective cohort studymedicine.diseaseSurgeryHealth CareAortic Dissection030228 respiratory systemPeople and PlacesCardiovascular AnatomyBlood VesselsPopulation GroupingsbusinessPLOS ONE
researchProduct

Acetazolamide treatment for infantile central sleep apnea.

2001

Central sleep apnea is a common respiratory pattern in healthy neonates. Nevertheless, frequent central sleep apnea associated with drops in oxygen saturation may contribute to infantile morbidity. Recently, low-dose acetazolamide was shown to reduce symptomatic central sleep apnea in adults. We treated 12 infants, median conceptional age 42 weeks (range, 40-44 weeks), with central sleep apnea. In all cases, the central apnea index was &gt;40/h total sleeping time (apnea ≥ 3 sec). The cumulative duration of drops in oxygen saturation below 90% was more than 3 min/h total sleeping time. All individuals received acetazolamide 7 mg/kg/day (orally, divided in three doses) for 11 weeks. Polysomn…

MaleCentral sleep apneaPolysomnographyPolysomnography030226 pharmacology & pharmacyDrug Administration ScheduleHypoxemia03 medical and health sciences0302 clinical medicineSleep Apnea SyndromesmedicineHumansOximetryRespiratory systemCarbonic Anhydrase InhibitorsOxygen saturation (medicine)medicine.diagnostic_testbusiness.industry05 social sciencesInfant Newborn050301 educationSleep apneaApneamedicine.diseaseAcetazolamideAnesthesiaPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessAcetazolamide0503 educationmedicine.drugJournal of child neurology
researchProduct

Workflow-centred open-source fully automated lung volumetry in chest CT

2019

Aim To develop a robust open-source method for fully automated extraction of total lung capacity (TLC) from computed tomography (CT) images and to demonstrate its integration into the clinical workflow. Materials and methods Using only open-source software, an algorithm was developed based on a region-growing method that does not require manual interaction. Lung volumes calculated from reconstructions with different kernels (TLCCT) were assessed. To validate the algorithm calculations, the results were correlated to TLC measured by pulmonary function testing (TLCPFT) in a subgroup of patients for which this information was available within 3 days of the CT examination. Results A total of 28…

MaleChest ct030218 nuclear medicine & medical imagingPulmonary function testing03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineHumansMedicineRadiology Nuclear Medicine and imagingSegmentationLung volumesRetrospective Studiesbusiness.industryGeneral MedicineMiddle Agedrespiratory systemRespiratory Function Testsrespiratory tract diseasesWorkflowOpen sourceFully automated030220 oncology & carcinogenesisLung volumetryRadiographic Image Interpretation Computer-AssistedFemaleRadiography ThoracicLung Volume MeasurementsTomography X-Ray ComputedNuclear medicinebusinessAlgorithmsSoftwareClinical Radiology
researchProduct

Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study

2019

Abstract Background Chronic Obstructive Pulmonary Disease (COPD) encompasses various phenotypes that severely limit the applicability of precision respiratory medicine. The present investigation is aimed to assess the circadian rhythm of symptoms in pre-defined clinical COPD phenotypes and its association with health-related quality of life (HR-QoL), the quality of sleep and the level of depression/anxiety in each clinical phenotype. Methods The STORICO (NCT03105999) Italian observational prospective cohort study enrolled COPD subjects. A clinical diagnosis of either chronic bronchitis (CB), emphysema (EM) or mixed COPD-asthma (MCA) phenotype was made by clinicians at enrollment. Baseline e…

MaleChronic bronchitisTime FactorsHealth StatusAnxietyHospital Anxiety and Depression ScaleSeverity of Illness IndexHealth StatuPulmonary Disease Chronic Obstructive0302 clinical medicineSurveys and QuestionnairesForced Expiratory VolumeClinical phenotypeMedicineSurveys and QuestionnaireRespiratory function030212 general & internal medicineProspective StudiesProspective cohort studyLungDepression (differential diagnoses)COPDDepressionMiddle AgedCircadian RhythmPhenotypeItalyAnxietyFemalemedicine.symptom24-hour symptoms Clinical phenotype Real-world Respiratory functionResearch ArticleHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyChronic ObstructiveTime FactorSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary Disease03 medical and health sciencesInternal medicineHumansAsthma24-hour symptoms; Clinical phenotype; Real-world; Respiratory function; Aged; Anxiety; Depression; Female; Forced Expiratory Volume; Health Status; Humans; Italy; Lung; Male; Middle Aged; Phenotype; Prospective Studies; Pulmonary Disease Chronic Obstructive; Severity of Illness Index; Sleep; Surveys and Questionnaires; Time Factors; Circadian Rhythm; Quality of LifeAgedlcsh:RC705-77924-hour symptomsbusiness.industryCorrectionlcsh:Diseases of the respiratory systemmedicine.disease24-hour symptomProspective Studie030228 respiratory systemReal-worldQuality of LifebusinessSleepRespiratory function
researchProduct

Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study

2016

Abstract: The cross-sectional relationship of obstructive sleep apnea with moderate to severe chronic kidney disease, defined as an estimated glomerular filtration rate = 30) was found in 34% of subjects. The lowest nocturnal oxygen saturation was 81 +/- 10.2%. Chronic kidney disease prevalence in the whole sample was 8.7% or 6.1%, according to the Modification of Diet in Renal Disease or the Chronic Kidney Disease-Epidemiology Collaboration equations, respectively. Subjects with lower estimated glomerular filtration rate were older, more obese, more often female, had worse obstructive sleep apnea and more co-morbidities (P < 0.001, each). With both equations, independent predictors of esti…

MaleComorbidityBody Mass IndexCohort StudiesBehavioral Neuroscience0302 clinical medicineRisk FactorsPrevalenceobstructive sleep apneaAged 80 and overSex CharacteristicsSleep Apnea ObstructiveMedicine (all)Sleep apneaGeneral MedicineMiddle AgedEuropeHypertensionCardiologynephropathyepidemiologyFemaleGlomerular Filtration RateCohort studyAdultmedicine.medical_specialtyAdolescentPolysomnographyCognitive NeuroscienceRenal functionSettore MED/10 - Malattie Dell'Apparato Respiratoriota3111NephropathyYoung Adult03 medical and health sciencesInternal medicinemedicineHumansObesityRenal Insufficiency ChronicAgedHeart Failurehypoxiabusiness.industrymedicine.diseaseOxygenObstructive sleep apneaCross-Sectional Studies030228 respiratory systemHeart failurePhysical therapyHuman medicinebusinessBody mass index030217 neurology & neurosurgeryKidney diseaseJournal of Sleep Research
researchProduct